
Carbios set to build closed-loop PET plant
Bottles, textile fibres, stirrers and plastic packaging made from PET (polyethylene terephtalate) are a major consituent of the 8 millions of...

Oxford BioTherapeutics in $450 deal with Wuxi Biologics
“Combining OxfordBioTherapeutic’s novel second generation immunoncolocy medicines with a major check-point pathway into a single entity, with...

Bio-plastics production grows to 7.5 million tonnes
Production of bio-based polymers will continue to grow at the same rate as petrochemical polymers and plastics resulting in a market share of...

Ose Pharma gets clinical milestone for IL7R antagonist
Under the deal inked in 2016, immuno-oncology and autoimmune specialist Ose Immunotherapeutics develops its IL-7-receptor...

Dewpoint Therapeutics kicks off with $60m financing
It’s always worth to start a company with a potential breakthrough approach in the Boston biotech area. At the end of January, Dewpoint...

SOBI and AstraZeneca in US$2bn+ deal on RSV antibodies
Though Synagis biosimilars are under development at South Korean Celltrion, Mabxience and Chinese iBio, palivizumab is currently the only...

XyloCor Therapeutics bags US$17m in Series A financing
The Amsterdam-based company said it will primarily use the proceeds to advance its lead product XC001, licenced from Weill Cornell Medicine, to...